What observations and effects could Covid-19 infection or Covid-19 vaccination have on women’s cycles? What observed menstrual changes are seen in women’s charts during this time, and how long do these persist? How could further data be collected for further research? View this Grand Rounds to explore early data observing the effects of covid 19, as well as the Covid 19 vaccination, on women’s cycle charts.
Dr. Patrick Yeung reviews the differences between ART/IVF and Restorative Reproductive Medicine (RRM) and the importance to offer alternatives to IVF to patients. Current surgical approaches and factors to consider in timing a laparoscopy for suspected endometriosis.
Dr. José Antonio and Dr. Stanford facilitate Q & A following the presentation.
Bruce A Lessey MD, PhD. discusses the biomarkers of endometrial receptivity and diagnostics for endometriosis, including the use of BCL6 testing. Review timing and synchrony of the embryo, progesterone, and endometrium that occur in a successful pregnancy. Discuss how to approach treatment and predict pregnancy outcomes with this information.
Professor Stephan Gordts presents a systematic minimal invasive exploration of so-called “unexplained infertility” (normal ultrasound/normal HSG) reveals the presence of pelvic pathology on 50-70 % of patients. In the absence of other fertility impairing factors, like male infertility, he looks at the different treatments of these pathologies to create the possibilities for normal conception.
How should we apply and use semen analysis testing and results in RRM and when should a semen analysis be considered for couples trying to conceive? What parameters should be evaluated, how are they measured and what is the clinical significance of the results?
Are there laboratory tests that have been abandoned because of ART, that could have application towards RRM? What about at-home “male fertility” testing kits? View this presentation and discussion with Craig Turczynski, PhD.
Prof Sunni Mumford will discuss emerging research investigating the role of vitamin D and other lifestyle and dietary factors on female reproductive health and couple fertility. Dr. Mumford is a reproductive and nutritional epidemiologist and Earl Stadtman Investigator in the Epidemiology Branch of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Her research focuses on modifiable dietary and lifestyle factors across the life course th…
Dr. Urrutia reviews the methodology and main findings of 2018 review on FABM effectiveness for avoiding pregnancy and disucsses the important limitations of the data including population-based differences in effectiveness, especially among breastfeeding and postpartum individuals. She also introduces and identifies clinical decision-making tools providers and patients regarding choosing an FABM to avoid pregnancy, reviews new technologies currently being applied to FABM use, and discusses the role of the FDA in clearing fertility awareness apps for contraception.
Dr. Whittaker reviews the success rates and limitations of ART and the treatments offered by the NaProTechnology (a version of restorative reproductive medicine) as well as its limitations. Develop an understanding of both approaches and better understand the impact on a societal level of ART.
This webinar explores the science, safety, and clinical application of botanical medicine (herbal medicine) options for reproductive health and in supporting hormonal balance. Treatment and support for common reproductive conditions such as PCOS, estrogen dominance, elevated androgens, thyroid support and ovarian reserve support. Dr. BreAnna Guan also covers botanical formulas for safety and clinical effectiveness as well as safety and herb/drug interaction in reproductive medicine.